Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs OnabotulinumtoxinA |
Security Level |
 |
Mechanism |
OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA. |
Management |
Monitor therapy |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs OnabotulinumtoxinA
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs OnabotulinumtoxinA Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of OnabotulinumtoxinA
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.